News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Flamel Technologies Announces Third Quarter Results
November 2, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LYON, France--(BUSINESS WIRE)--Flamel Technologies (NASDAQ: FLML) today announced its financial results for the third quarter of 2006.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
CAR-T
J&J hands lymphoma bispecific CAR T back to AbelZeta
August 17, 2026
·
2 min read
·
Tristan Manalac
Insights
Italian biotech gains momentum as VC funding, tech transfer environment improve
August 17, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Drug Development
Capricor soars on potential FDA review extension, filing amendments
August 14, 2026
·
4 min read
·
Gabrielle Masson
Regulatory
Pressure piles on Amgen after EU pulls Tavneos, flags ‘serious breaches’ in pivotal study
August 14, 2026
·
2 min read
·
Tristan Manalac
